Originally published byEU-Startups
Alcolase, a Copenhagen-based BioTech startup tackling alcohol intolerance by providing remedies for alcohol flush, today announced a €1.5 million funding round supported by Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and a group of business angels. The company plans to first enter the Singapore market, followed by South Korea, where alcohol intolerance is more […]
The post Copenhagen’s Alcolase secures €1.5 million to develop enzyme-based remedy for alcohol flush appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Even Claude agrees: hole in its sandbox was real and dangerous
1d ago
Intel's CEO reveals early hiring challenges as bankruptcy concerns deterred top talent
1d ago
OpenAI floats buy-before-your-try AI availability guarantee
1d ago
Beyond a sleek interface: The new wave of European fintech
17h ago
UK Typhoon jets fitted with bargain-bin drone busters for Middle East sorties
2d ago